DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
8.33
+0.32 (4.00%)
Oct 9, 2026, 4:00 PM EDT - Market closed
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $449.2 million as of October 9, 2026. It is the 15,652nd most valuable company in the world and the 2,842nd biggest in the United States. Its market cap has increased by 24.85% in one year.
Market Cap
449.20M
Enterprise Value
405.88M
1-Year Change
24.85%
Global Rank
Country Rank
#2,842 United States
Category
ChartMarket Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $449.20M, an increase of 1,123.98%. That is a compound annual growth rate of 37.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 449.20M | 8.37% |
| Dec 31, 2025 | 414.50M | 78.51% |
| Dec 31, 2024 | 232.20M | 115.40% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
| Dec 7, 2018 | 36.70M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Assembly Biosciences | 464.63M |
| Ovid Therapeutics | 457.00M |
| ARS Pharmaceuticals | 454.47M |
| AgomAb Therapeutics NV | 454.07M |
| Tectonic Therapeutic | 444.16M |
| Prothena Corporation | 442.52M |
| Editas Medicine | 436.17M |
| Entera Bio | 431.12M |